Search the Newsreel

Dr. Sulaiman Al-Habib Medical Services Group Co. Financial Disclosures & Filings

SBC Medical Group Holdings Incorporated Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

S&CO Inc. Invests $6.40 Million in Revolution Medicines, Inc. $RVMD

S&CO Inc. recently invested $6.4 million in Revolution Medicines, Inc. (NASDAQ:RVMD) by purchasing 34,171 shares, contributing to institutional ownership of 94.34%. Despite a larger-than-expected quarterly loss, analysts maintain a "Moderate Buy" rating with a consensus price target of $161.79. Insider transactions show mixed activity, …

State of Wyoming Buys Shares of 9,446 Revolution Medicines, Inc. $RVMD

The State of Wyoming recently acquired 9,446 shares of Revolution Medicines, Inc. (NASDAQ:RVMD) valued at approximately $1.77 million, marking a new position in the biopharmaceutical company. This move comes as institutional investors and hedge funds collectively hold 94.34% of RVMD's stock. Despite a recent …

Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)?

Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of "Moderate Buy" by Analysts

Number of shareholders of Twareat Medical Care Co. – TADAWUL:9627

ICU Medical, Inc. (NASDAQ:ICUI) Given Average Rating of "Moderate Buy" by Brokerages

ICU Medical, Inc. (NASDAQ:ICUI) has received a "Moderate Buy" consensus rating from nine analysts, with an average 12-month price target of $192.80. The company recently surpassed quarterly earnings and revenue expectations, reporting $2.37 EPS on $547.88 million in revenue, and provided fiscal 2026 EPS …

9,840 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB recently acquired 9,840 shares of Praxis Precision Medicines (NASDAQ:PRAX) valued at approximately $3.29 million, contributing to institutional investors owning 67.84% of the company. Praxis Precision Medicines reported a smaller-than-expected quarterly loss of $2.87 per share and holds a consensus "Buy" rating …

Inspire Medical Systems (INSP) Stock May Be Cheap After A 74% Fall

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Inspire Medical Systems stock has had a difficult run over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples …

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of "Hold" from Brokerages

TransMedics Group, Inc. (NASDAQ:TMDX) has received a consensus "Hold" rating from brokerages, with six analysts recommending "buy," six "hold," and one "sell." The average 12-month price target for the stock is $124.18. The company recently reported quarterly revenue of $189.95 million, exceeding estimates, but …

Tian An Medicare (SEHK:383) Stock Trails Revenue Progress With Margin Squeeze

Orthofix (OFIX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief IR and Communications Officer - Julie Dewey President and Chief Executive Officer - Massimo Calafiore Chief Financial Officer - Julie Andrews Full Conference Call Transcript Operator: Thank …

Top Generate Biomedicines (GENB) Competitors 2026

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook

Orthofix Medical's updated outlook reflects a rebound in bone growth stimulation reimbursement and improved trends in biologics and limb reconstruction, partially offset by a steeper-than-expected decline among smaller U.S. spine distributors. The company expects third-quarter revenue to be similar to the second quarter with …

Outset Medical (OM) Q2 2026 Earnings Call Transcript

Inspire Medical Systems (INSP) Updates Guidance As Valuation Questions Persist

Kestra Medical Technologies CEO Brian Webster sells $692,214 in stock

Kestra Medical Technologies CEO Brian Webster recently sold $692,214 worth of company stock across three transactions between July 30 and August 3, 2026. These sales were nondiscretionary, executed to cover tax withholding obligations related to restricted stock unit vesting. The company has seen significant …

Kestra Medical Technologies officer Traci Umberger sells $512,791 By Investing.com

Kestra Medical Technologies CCO sells $642k in shares

Kestra Medical CBO Timothy Moran sells $348,310 in shares

Kestra Medical's CBO, Timothy P. Moran, sold $348,310 worth of common shares in late July and early August 2026 to cover tax withholding obligations. Following these transactions, Moran directly owns 66,345 shares. The stock has appreciated significantly since then, despite the company missing Wall …

Kestra Medical Technologies officer Traci Umberger sells $512,791

Traci S. Umberger, General Counsel and Chief Administrative Officer at Kestra Medical Technologies, sold common shares worth $512,791 between July 30 and August 3, 2026. These non-discretionary sales were conducted to cover tax withholding obligations related to restricted stock unit vesting. Following these transactions, …

TransMedics Group (TMDX) Is Up 5.6% After Raising 2026 Revenue Guidance Despite EPS Compression

CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $13

CCORF has reiterated its Buy rating for Orthofix Medical (OFIX.US), maintaining a target price of $13. This indicates a continued positive outlook on the company's stock performance by the firm.

Q1 2026 ICU Medical Inc Earnings Call Transcript

This article provides the edited transcript of ICU Medical Inc.'s Q1 2026 earnings call, which took place on May 7, 2026. The call began with an introduction from an unidentifiable speaker, followed by Thompson from ICR who welcomed participants to discuss the financial results. …

Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum

Merit Medical Systems (MMSI) is developing a new long-range plan, building on recent revenue and margin growth under new CEO Martha. The company has reorganized its reporting structure into Foundational and Therapeutic product categories and is focusing on disciplined M&A to deepen existing market …

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Merit Medical Systems, Inc. $MMSI Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Merit Medical Systems (MMSI) by 200.3% in the first quarter, now owning 17,612 shares valued at approximately $1.21 million. This comes as institutional investors collectively hold 99.66% of the stock, and analysts maintain a "Moderate …

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …

SBC Medical Group (NASDAQ:SBC) Stock Rating Upgraded by Wall Street Zen

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News

The article provides information related to Parabilis Medicines (PBLS) stock options chain, including quotes and news. The content itself is not available in the provided input.

Prime Medicine, Inc. Stock 12‑Month Price Target Cut to $6.92, Implies 124% Upside

The average 12-month price target for Prime Medicine, Inc. (PRME) stock has been lowered from $7.12 to $6.92 by 9 analysts, yet this new target still suggests a significant 124% potential upside from its August 14th closing price. The consensus rating for PRME remains …

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …